These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37793327)

  • 1. Antiparasitic activity of ivermectin: Four decades of research into a "wonder drug".
    Sulik M; Antoszczak M; Huczyński A; Steverding D
    Eur J Med Chem; 2023 Dec; 261():115838. PubMed ID: 37793327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New indications of ivermectin].
    Caumes E; Danis M
    Rev Med Interne; 2001 Apr; 22(4):379-84. PubMed ID: 11586522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Over 25 Years of Clinical Experience With Ivermectin: An Overview of Safety for an Increasing Number of Indications.
    Kircik LH; Del Rosso JQ; Layton AM; Schauber J
    J Drugs Dermatol; 2016 Mar; 15(3):325-32. PubMed ID: 26954318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ivermectin, a potential anticancer drug derived from an antiparasitic drug.
    Tang M; Hu X; Wang Y; Yao X; Zhang W; Yu C; Cheng F; Li J; Fang Q
    Pharmacol Res; 2021 Jan; 163():105207. PubMed ID: 32971268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ivermectin in human medicine, an overview of the current status of its clinical applications.
    González P; González FA; Ueno K
    Curr Pharm Biotechnol; 2012 May; 13(6):1103-9. PubMed ID: 22039800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repositioning Ivermectin for Covid-19 treatment: Molecular mechanisms of action against SARS-CoV-2 replication.
    Low ZY; Yip AJW; Lal SK
    Biochim Biophys Acta Mol Basis Dis; 2022 Feb; 1868(2):166294. PubMed ID: 34687900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lessons from the History of Ivermectin and Other Antiparasitic Agents.
    Campbell WC
    Annu Rev Anim Biosci; 2016; 4():1-14. PubMed ID: 26515271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ivermectin.
    Elgart GW; Meinking TL
    Dermatol Clin; 2003 Apr; 21(2):277-82. PubMed ID: 12757250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antiparasitic agent ivermectin induces chloride-dependent membrane hyperpolarization and cell death in leukemia cells.
    Sharmeen S; Skrtic M; Sukhai MA; Hurren R; Gronda M; Wang X; Fonseca SB; Sun H; Wood TE; Ward R; Minden MD; Batey RA; Datti A; Wrana J; Kelley SO; Schimmer AD
    Blood; 2010 Nov; 116(18):3593-603. PubMed ID: 20644115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. History of avermectin and ivermectin, with notes on the history of other macrocyclic lactone antiparasitic agents.
    Campbell WC
    Curr Pharm Biotechnol; 2012 May; 13(6):853-65. PubMed ID: 22039784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ivermectin: From theory to clinical application.
    Ashour DS
    Int J Antimicrob Agents; 2019 Aug; 54(2):134-142. PubMed ID: 31071469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wonder drug for worms: A review of three decades of ivermectin use in dermatology.
    Gowtham S; Karthikeyan K
    Indian J Dermatol Venereol Leprol; 2019; 85(6):674-678. PubMed ID: 31552839
    [No Abstract]   [Full Text] [Related]  

  • 13. From hydroxychloroquine to ivermectin: what are the anti-viral properties of anti-parasitic drugs to combat SARS-CoV-2?
    Rakedzon S; Neuberger A; Domb AJ; Petersiel N; Schwartz E
    J Travel Med; 2021 Feb; 28(2):. PubMed ID: 33480414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ivermectin 20 years on: maturation of a wonder drug.
    Geary TG
    Trends Parasitol; 2005 Nov; 21(11):530-2. PubMed ID: 16126457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ivermectin: A Review in Rosacea.
    Deeks ED
    Am J Clin Dermatol; 2015 Oct; 16(5):447-52. PubMed ID: 26254001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacokinetics and interactions of ivermectin in humans--a mini-review.
    González Canga A; Sahagún Prieto AM; Diez Liébana MJ; Fernández Martínez N; Sierra Vega M; García Vieitez JJ
    AAPS J; 2008; 10(1):42-6. PubMed ID: 18446504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ivermectin: uses and impact 20 years on.
    Fox LM
    Curr Opin Infect Dis; 2006 Dec; 19(6):588-93. PubMed ID: 17075336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ivermectin: pharmacology and application in dermatology.
    Dourmishev AL; Dourmishev LA; Schwartz RA
    Int J Dermatol; 2005 Dec; 44(12):981-8. PubMed ID: 16409259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ivermectin in dermatology: why it 'mite' be useless against COVID-19.
    Roche D; O'Connor C; Murphy M
    Clin Exp Dermatol; 2021 Oct; 46(7):1327-1328. PubMed ID: 33896010
    [No Abstract]   [Full Text] [Related]  

  • 20. Ivermectin in dermatology.
    del Giudice P; Chosidow O; Caumes E
    J Drugs Dermatol; 2003 Jan; 2(1):13-21. PubMed ID: 12852376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.